报价延迟最少15分钟:2026/02/10 05:55 EST
盘前时段
|
||||
|
-- 
|
|
|
常规时段 (已结束)
|
|
|
|
|
||||||||||||
|
|
|
|
|
8.04
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.35/1.17
|
|
企业价值
302.69M
|
| 资产负债 |
|
每股账面净值
0.78
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
56.13M
|
|
每股收益
1.85
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others. |
